Skip to main content

Advertisement

Articles

Page 2 of 46

  1. Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy, selecting a more maligna...

    Authors: Maria Carla Bosco, Gabriella D’Orazi and Donatella Del Bufalo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:8

    Content type: Commentary

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:43

  2. Long noncoding RNAs (lncRNAs) are involved in the progression of various cancers and affect the response to radiotherapy. This study focused on clarifying the underlying mechanism by which lncTUG1 affects the ...

    Authors: Pan Wang, Zhuanbo Yang, Ting Ye, Fei Shao, Jiagen Li, Nan Sun and Jie He

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:7

    Content type: Research

    Published on:

  3. Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to c...

    Authors: Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, Silvia Careccia, Michele Signore, Tobias Longin Haas, Federico Salaris, Marta Baiocchi, Alessandra Boe, Alessandro Giuliani, Olga Tcheremenskaia, Alfredo Pagliuca, Ombretta Guardiola, Gabriella Minchiotti, Lidia Colace, Antonio Ciardi…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:2

    Content type: Research

    Published on:

  4. Recent evidence indicates that metformin inhibits mammalian cancer growth and metastasis through the regulation of microRNAs. Metformin regulates miR-381 stability, which plays a vital role in tumor progressio...

    Authors: Dan Jin, Jiwei Guo, Yan Wu, Weiwei Chen, Jing Du, Lijuan Yang, Xiaohong Wang, Kaikai Gong, Juanjuan Dai, Shuang Miao, Xuelin Li and Guoming Su

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:6

    Content type: Research

    Published on:

  5. LncRNA LINC00662 is closely related to the occurrence and development of cancer. This study aims to explore the effect of LINC00662 on colon cancer tumor growth and metastasis and its molecular mechanism.

    Authors: Bo Cheng, Aimei Rong, Quanbo Zhou and Wenlu Li

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:5

    Content type: Research

    Published on:

  6. MiR-199a-3p (miR-199a) can enhance the chemosensitivity of hepatocellular carcinoma (HCC). Because of the easy degradation of miRNA by direct infusion, effective vehicle-mediated delivery of miR-199a may repre...

    Authors: Guohua Lou, Liang Chen, Caixia Xia, Weina Wang, Jinjin Qi, Aichun Li, Liying Zhao, Zhi Chen, Min Zheng and Yanning Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:4

    Content type: Research

    Published on:

  7. Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women. Treatment with PARP inhibitors (PARPi), such as Olaparib, has been recently introd...

    Authors: Enrica Vescarelli, Giulia Gerini, Francesca Megiorni, Eleni Anastasiadou, Paola Pontecorvi, Luciana Solito, Claudia De Vitis, Simona Camero, Claudia Marchetti, Rita Mancini, Pierluigi Benedetti Panici, Carlo Dominici, Ferdinando Romano, Antonio Angeloni, Cinzia Marchese and Simona Ceccarelli

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:3

    Content type: Research

    Published on:

  8. Circular RNA nuclear factor I X (circNFIX) has been reported to play an important role in glioma progression. However, the mechanism by which circNFIX participates in glioma progression remains poorly understood.

    Authors: Chenyu Ding, Zanyi Wu, Honghai You, Hongliang Ge, Shufa Zheng, Yuanxiang Lin, Xiyue Wu, Zhangya Lin and Dezhi Kang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:506

    Content type: Research

    Published on:

  9. Liver cancer stem cells (LCSCs) contribute to hepatocellular carcinoma (HCC) development, metastasis, and drug resistance. MSI2 and Notch1 signaling are involved in the maintenance of CSCs. However, it is unkn...

    Authors: Xiju Wang, Ronghua Wang, Shuya Bai, Si Xiong, Yawen Li, Man Liu, Zhenxiong Zhao, Yun Wang, Yuchong Zhao, Wei Chen, Timothy R. Billiar and Bin Cheng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:505

    Content type: Research

    Published on:

  10. MKK3 is a member of the dual specificity kinase group specific upstream activator of p38 MAPK proteins. We originally identified MKK3 as mutant p53 (mutp53) gain-of-function (GOF) upregulated target gene in di...

    Authors: Lorenzo Stramucci and Gianluca Bossi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:504

    Content type: Commentary

    Published on:

  11. The treatment of metastatic osteosarcoma (OS) remains a challenge for oncologists, and novel therapeutic strategies are urgently needed. An understanding of the pathways that regulate OS dissemination is requi...

    Authors: Cinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, Marianna Carrabotta, Sara Greco, Rosa Simona Pinca, Cristina Ferrari, Lorena Landuzzi, Michela Pasello, Pier-Luigi Lollini, Marco Gambarotti, Davide Maria Donati and Katia Scotlandi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:503

    Content type: Research

    Published on:

  12. Gastric cancer (GC) is one of the most prevalent and deadly malignancies worldwide. Accumulating reports have indicated the participation of long non-coding RNAs (lncRNAs) in the onset and progression of GC.

    Authors: Yangyang Dong, Xinyu Li, Zhibin Lin, Wenbing Zou, Yan Liu, Huiyang Qian and Jing Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:502

    Content type: Research

    Published on:

  13. Esophageal cancer is one of the most common malignant tumors in the world. With currently available therapies, only 20% ~ 30% patients can survive this disease for more than 5 years. TRAIL, a natural ligand fo...

    Authors: Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao and Baoen Shan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:501

    Content type: Research

    Published on:

  14. In the original publication of this article [1], the author found an error in Fig. 2f. lncGPR107 should be changed to lncMAPK6, and the corrected Fig. 2 is shown below.

    Authors: Guanqun Huang, Hui Jiang, Yueming He, Ye Lin, Wuzheng Xia, Yuanwei Luo, Min Liang, Boyun Shi, Xinke Zhou and Zhixiang Jian

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:500

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:105

  15. Mortalin is enriched in a large variety of cancers and has been shown to contribute to proliferation and migration of cancer cells in multiple ways. It has been shown to bind to p53 protein in cell cytoplasm a...

    Authors: Jayarani F. Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, Tomoko Yaguchi, Durai Sundar, Sunil C. Kaul and Renu Wadhwa

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:499

    Content type: Research

    Published on:

  16. The MYCN amplification is a defining hallmark of high-risk neuroblastoma. Due to irregular oncogenes orchestration, tumor cells exhibit distinct fatty acid metabolic features from non-tumor cells. However, the...

    Authors: Yi Ding, Jie Yang, Yawen Ma, Tengteng Yao, Xingyu Chen, Shengfang Ge, Lihua Wang and Xianqun Fan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:498

    Content type: Research

    Published on:

  17. The survival of pancreatic cancer patients remains poor. However, the underlying molecular mechanism and new therapeutic target of pancreatic cancer are still needed to be found. Many studies have shown that t...

    Authors: Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv and Yuantin Gu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:497

    Content type: Research

    Published on:

  18. In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.

    Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:496

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:436

  19. Human bone marrow mesenchymal stem cells (hBMSCs) are implicated in cancer initiation and metastasis, sometimes by releasing exosomes that mediate cell communication by delivering microRNAs (miRNAs). This stud...

    Authors: Shuangjian Jiang, Chengqiang Mo, Shengjie Guo, Jintao Zhuang, Bin Huang and Xiaopeng Mao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:495

    Content type: Research

    Published on:

  20. Downregulation of microRNA-338-3p (miR-338-3p) was detected in many malignant tumors, which indicated miR-338-3p might serve as a role of antioncogene in those cancers. The present study aimed to explore the r...

    Authors: Ruitao Zhang, Huirong Shi, Fang Ren, Wei Feng, Yuan Cao, Gailing Li, Zheying Liu, Pengcheng Ji and Minghui Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:494

    Content type: Research

    Published on:

  22. Molecular mechanisms driving acquired resistance to anti-EGFR therapies in metastatic colorectal cancer (mCRC) are complex but generally involve the activation of the downstream RAS-RAF-MEK-MAPK pathway. Never...

    Authors: S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello and T. Troiani

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:492

    Content type: Research

    Published on:

  23. Growing evidence showed the increased prevalence of cancer incidents, particularly colorectal cancer, among type 2 diabetic mellitus patients. Antidiabetic medications such as, insulin, sulfonylureas, dipeptyl...

    Authors: Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou and Ishwar Parhar

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:491

    Content type: Review

    Published on:

  24. N-myc downstream-regulated gene 1 (NDRG1) has been shown to play a key role in tumor metastasis. Recent studies demonstrate that NDRG1 can suppress tumor growth and is related to tumor proliferation; however, ...

    Authors: Sen Zhang, Chaoran Yu, Xiao Yang, Hiju Hong, Jiaoyang Lu, Wenjun Hu, Xiaohui Hao, Shuchun Li, Batuer Aikemu, Guang Yang, Zirui He, Luyang Zhang, Pei Xue, Zhenghao Cai, Junjun Ma, Lu Zang…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:490

    Content type: Research

    Published on:

  25. Ischemia reperfusion injury (IRI) has been shown to increase the risk of tumor recurrence after liver surgery. Also, nonalcoholic fatty liver disease (NAFLD) is associated with increased HCC recurrence. ALOX12...

    Authors: Faji Yang, Yuheng Zhang, Haozhen Ren, Jinglin Wang, Longcheng Shang, Yang Liu, Wei Zhu and Xiaolei Shi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:489

    Content type: Research

    Published on:

  26. Accumulating evidence indicates that aberrant microRNA (miRNA) expression contributes to osteosarcoma progression. This study aimed to elucidate the association between miR-624-5p expression and osteosarcoma (...

    Authors: Yongjun Luo, Wei Liu, Pengyu Tang, Dongdong Jiang, Changjiang Gu, Yumin Huang, Fangyi Gong, Yuluo Rong, Dingfei Qian, Jian Chen, Zheng Zhou, Shujie Zhao, Jiaxing Wang, Tao Xu, Yongzhong Wei, Guoyong Yin…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:488

    Content type: Research

    Published on:

  27. Arsenic sulfide was found to have potential anti-cancer activities, especially in gastric cancer. However, the underlying mechanism need to be further explored. This study was aimed to investigate the mechanis...

    Authors: Ting Kang, Maolin Ge, Ruiheng Wang, Zhen Tan, Xiuli Zhang, Chuanying Zhu, Han Liu and Siyu Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:487

    Content type: Research

    Published on:

  28. Gliomas are common life-threatening cancers, mainly due to their aggressive nature and frequent invasiveness and long non-coding RNAs (lncRNAs) are emerging as promising molecular targets. Therefore, we explor...

    Authors: Haiyang Xu, Guifang Zhao, Yu Zhang, Hong Jiang, Weiyao Wang, Donghai Zhao, Hongquan Yu and Ling Qi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:486

    Content type: Research

    Published on:

  29. Recent studies have reported that Integrin alpha 2 (ITGA2) plays an essential role in tumor cell proliferation, invasion, metastasis, and angiogenesis. An abnormally expressed ITGA2 correlates with unfavorable...

    Authors: Dianyun Ren, Jingyuan Zhao, Yan Sun, Dan Li, Zibo Meng, Bo Wang, Ping Fan, Zhiqiang Liu, Xin Jin and Heshui Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:485

    Content type: Research

    Published on:

  30. Protein tyrosine phosphatase receptor delta (PTPRD) is frequently inactivated in various types of cancers. Here, we explored the underlying mechanism of PTPRD-loss-induced cancer metastasis and investigated an...

    Authors: Won Jung Bae, Ji Mi Ahn, Hye Eun Byeon, Seokwhi Kim and Dakeun Lee

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:484

    Content type: Research

    Published on:

  31. The dysfunction of type I interferon (IFN) signaling is an important mechanism of immune escape and metastasis in tumors. Increased NOS1 expression has been detected in melanoma, which correlated with dysfunct...

    Authors: Pengfei Xu, Shuangyan Ye, Keyi Li, Mengqiu Huang, Qianli Wang, Sisi Zeng, Xi Chen, Wenwen Gao, Jianping Chen, Qianbing Zhang, Zhuo Zhong, Ying Lin, Zhili Rong, Yang Xu, Bingtao Hao, Anghui Peng…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:483

    Content type: Research

    Published on:

  32. Identification of novel cancer-associated splice variants is of potential diagnostic, prognostic and therapeutic importance. NF-Y transcription factor is comprised of NF-YA, NF-YB and NF-YC subunits, binds inv...

    Authors: Lucia Cappabianca, Antonietta Rosella Farina, Lucia Di Marcotullio, Paola Infante, Daniele De Simone, Michela Sebastiano and Andrew Reay Mackay

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:482

    Content type: Research

    Published on:

  33. Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors induces a cancer stem cell (CSC) phenotype. Her...

    Authors: Jiahui Si, Yuanyuan Ma, Ji Wang Bi, Ying Xiong, Chao Lv, Shaolei Li, Nan Wu and Yue Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:481

    Content type: Research

    Published on:

  34. In the original publication of this article [1], Fig. 6 is wrong and the updated figure is shown below.

    Authors: Xiao-Ping Chen, Xin Long, Wen-long Jia, Han-Jie Wu, Jing Zhao, Hui-Fang Liang, Arian Laurence, Jun Zhu, Dong Dong, Yan Chen, Long Lin, Yu-Dong Xia, Wei-Yang Li, Gui-Bo Li, Zhi-Kun Zhao, Kui Wu…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:480

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:261

  35. Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibi...

    Authors: Xiaoming Bai, Jiaofang Shao, Sujin Zhou, Zhenggang Zhao, Fanghong Li, Rong Xiang, Allan Z. Zhao and Jinshun Pan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:479

    Content type: Research

    Published on:

  36. KH-type splicing regulatory protein (KHSRP) plays an important role in cancer invasion, but the relevant mechanism is not well known. In the present study, we investigated the function and potential molecular ...

    Authors: Mingxia Yan, Lei Sun, Jing Li, Huajian Yu, Hechun Lin, Tao Yu, Fangyu Zhao, Miaoxin Zhu, Lei Liu, Qin Geng, Hanwei Kong, Hongyu Pan and Ming Yao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:478

    Content type: Research

    Published on:

  37. In recent years, long non-coding RNAs (lncRNAs) are of great importance in development of different types of tumors, while the function of lncRNA ZFAS1 is rarely discussed in esophageal squamous cell carcinoma...

    Authors: Zhirong Li, Xuebo Qin, Wei Bian, Yishuai Li, Baoen Shan, Zhimeng Yao and Shujun Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:477

    Content type: Research

    Published on:

  38. Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lac...

    Authors: Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, Chen-Song Huang, Xi-Tai Huang, Jie-Qin Wang, Zhuo-Xing Gao, Shi-Jin Li, Qiong-Cong Xu, Wei Zhao and Xiao-Yu Yin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:476

    Content type: Research

    Published on:

  39. Forkhead box G1 (FOXG1) is a member of the Fox transcription factor family involved in regulation of many cancers. However, the role of FOXG1 in hepatocellular carcinogenesisis largely unclear. The present stu...

    Authors: Xingrong Zheng, Jiaxin Lin, Hewei Wu, Zhishuo Mo, Yunwen Lian, Peipei Wang, Zhaoxia Hu, Zhiliang Gao, Liang Peng and Chan Xie

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:475

    Content type: Research

    Published on:

  40. The inflammatory cytokine interleukin-6 (IL-6) is critical for the expression of octamer-binding transcription factor 4 (OCT4), which is highly associated with early tumor recurrence and poor prognosis of hepa...

    Authors: Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:474

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:10

  41. Circulating tumour cells (CTCs), especially mesenchymal CTCs, are important determinants of metastasis, which leads to most recurrence and mortality in hepatocellular carcinoma (HCC). However, little is known ...

    Authors: Yujun Tang, Yishi Lu, Yuan Chen, Lei Luo, Lei Cai, Bangjian Peng, Wenbin Huang, Hangyu Liao, Liang Zhao and Mingxin Pan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:473

    Content type: Research

    Published on:

  42. Alteration of signalling pathways regulating cell cycle progression is a common feature of cancer cells. Several drugs targeting distinct phases of the cell cycle have been developed but the inability of many ...

    Authors: Ouma Cisse, Muzthahid Quraishi, Federico Gulluni, Federica Guffanti, Ioanna Mavrommati, Methushaa Suthanthirakumaran, Lara C. R. Oh, Jessica N. Schlatter, Ambisha Sarvananthan, Massimo Broggini, Emilio Hirsch, Marco Falasca and Tania Maffucci

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:472

    Content type: Research

    Published on:

  43. Adhesion molecules distributed on the cell-surface depends upon their dynamic trafficking that plays an important role during cancer progression. ADP-ribosylation factor 6 (Arf6) is a master regulator of membr...

    Authors: Shanshan Qi, Linjia Su, Jing Li, Chuanshan Zhang, Zhe Ma, Guiqiu Liu, Qing Zhang, Guhe Jia, Yongjun Piao and Sihe Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:471

    Content type: Research

    Published on:

  44. Accumulation evidence indicates the vital role of long non-coding RNAs (lncRNAs) in tumorigenesis and the progression of malignant tumors, including pancreatic cancer (PC). However, the role and the molecular ...

    Authors: Shan Lei, Zhiwei He, Tengxiang Chen, Xingjun Guo, Zhirui Zeng, Yiyi Shen and Jianxin Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:470

    Content type: Research

    Published on:

  45. The activation of tumour-associated macrophages (TAMs) contributes to the progression of hepatocellular carcinoma (HCC). SIRT4 acts as a tumour suppressor of tumour growth by regulating cell metabolism, inflam...

    Authors: Zhi Li, He Li, Zhi-Bo Zhao, Wei Zhu, Pan-Pan Feng, Xi-Wen Zhu and Jian-Ping Gong

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:469

    Content type: Research

    Published on:

  46. The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to ta...

    Authors: Yuchong Peng, Youhong Liu, Yingxue Gao, Bowen Yuan, Xuli Qi, Yuxin Fu, Qianling Zhu, Tuoyu Cao, Songwei Zhang, Linglong Yin and Xiong Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:468

    Content type: Research

    Published on:

  47. The NSD family of histone lysine methyltransferases have emerged as important biomarkers that participate in a variety of malignancies. Recent evidence has indicated that somatic dysregulation of the nuclear r...

    Authors: Shuhua Zhang, Fan Zhang, Qing Chen, Chidan Wan, Jun Xiong and Jianqun Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:467

    Content type: Research

    Published on:

  48. Circular RNAs (circRNAs) have recently been shown to play important roles in different tumors. However, their detailed roles and regulatory mechanisms in pancreatic ductal adenocarcinoma (PDAC) are not well un...

    Authors: Yan Chen, Zhonghu Li, Mengyun Zhang, Bo Wang, Jiaxin Ye, Yang Zhang, Di Tang, Dandan Ma, Weidong Jin, Xiaowu Li and Shuguang Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:466

    Content type: Research

    Published on:

  49. Prostate cancer (PCa) is a leading cause of cancer-related death in males worldwide. Exacerbated inflammation and angiogenesis have been largely demonstrated to contribute to PCa progression. Diverse naturally...

    Authors: Denisa Baci, Antonino Bruno, Caterina Cascini, Matteo Gallazzi, Lorenzo Mortara, Fausto Sessa, Giuseppe Pelosi, Adriana Albini and Douglas M. Noonan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:464

    Content type: Research

    Published on:

  50. We investigated the role of PD-L1 in the metabolic reprogramming of non-small cell lung cancer (NSCLC).

    Authors: Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A. Kim, Jin Chul Paeng, Chan-Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung and Yoon Kyung Jeon

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:462

    Content type: Research

    Published on:

Follow

Annual Journal Metrics

Advertisement

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us